We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Lidco Group Plc | LSE:LID | London | Ordinary Share | GB0030546849 | ORD 0.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.75 | 11.50 | 12.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
27/3/2017 10:07 | Hi myosite, I don't think so, time will tell. | gbenson1 | |
26/3/2017 19:46 | gbenson you got rid of the wrong one | myosite | |
24/3/2017 08:41 | gbenson, thats why we like to hear from The Count and Gobbygnome cos they forecast Major things for this company over a decade ago, particularly as they knew all about this technology and were well in with the management. Nobby used to meet directors in the British Airways 1st class lounge you know and can be found on TYRU board still telling the world how many shares he is buying and how his new product sold 1 or 2 boxes of NIT KILLER at his local store last week. | willib2 | |
23/3/2017 15:00 | Begs the question of course on why you are reading this board and not just posting on the Doomedtex board | trentendboy | |
23/3/2017 14:31 | Hi Beeston boy, I used to hold both, but now just Del for future earnings, nameste. | gbenson1 | |
23/3/2017 14:13 | LOL. You need a sense of history benson. Do you not know the sector and who LIDS main competitors are? This is clearly of direct relevace to the share price of LID (which is similarly languishing) | trentendboy | |
23/3/2017 13:15 | Thought this was a Lid bb, nothing positive to say move on, obviously nothing happening here ?? | gbenson1 | |
23/3/2017 12:35 | Dread to think the total dilution he has suffered - must be a massive percentage over the last 10 years | trentendboy | |
22/3/2017 23:02 | Nothing from THE COUNT or GOBBYNOBBY. | willib2 | |
22/3/2017 09:30 | The dilution simply never ends. It is astonishing really. | trentendboy | |
13/3/2017 19:33 | Dont think chrisdgob has ever posted before, and he is a prolific poster. | willib2 | |
08/3/2017 18:53 | Thats what the visiting fans sing to the Trent End! | bigt20 | |
07/3/2017 20:38 | All gone quiet over there | trentendboy | |
07/3/2017 08:58 | Willib2, you were right 'I'm Out' for now. | gbenson1 | |
07/3/2017 08:28 | Shocking isn't it. Losing more per year than deltex. Just.... | trentendboy | |
06/3/2017 22:58 | O/T TrentEndBoy, Are Robin Hoods boys still losing £20m a season? Its not as if they are competing at the top end of the Championship.... | bigt20 | |
06/3/2017 07:48 | Trump summarises deltex holders up perfectly | trentendboy | |
01/3/2017 18:35 | gbenson1. Agreed but his last 2 positions are far more relevant to a medical devices coy - Though given the performance of LID the Scaffolding experience might be necessary to prop up the coy. Declaration I used to hold but sold out at a small profit many years ago - but still keep an eye on it as the product appears to be a "should have" but sales traction is missing - Not close enough to surgical practice to determine why not - Any surgeons able to comment ? | pugugly | |
01/3/2017 13:36 | PUGUGLY, ITS IN THE RNS towards the END.... | gbenson1 | |
01/3/2017 13:08 | To all Deltex investors, which will get priority. Purchase ODM, or change the logo's. | willib2 | |
01/3/2017 10:23 | gbenson, OH DEAR and have you noticed PUGUGLY seems to have an extremely diverse amount of companies in his portfolio. | willib2 | |
01/3/2017 10:21 | GBENSON1; You seem to have the wrong Peter Grant. From the rns he was previously with Abzena and from their web site "Peter Grant Non-Executive Director, Abzena plc Peter was Chief Executive Officer of Skyepharma PLC from January 2012 to June 2016, when the company merged with Vectura Group plc. He joined Skyepharma as Chief Financial Officer in November 2006. Previously Peter was Interim Chief Executive Officer of Voice Commerce Group, Group Finance Director at Eurodis Electron plc, Chief Financial Officer at WorldPay plc and Group Finance Director then Group Chief Executive at Molins plc. Prior to this Peter held a variety of senior commercial, financial and general management roles in the General Electric Company plc group of companies. He was previously a Non-Executive Director of ShipServ, Inc. He holds an MA in Mathematics from the University of Oxford and is a Chartered Accountant." | pugugly | |
01/3/2017 10:20 | gbenson, be positive and cease dilly dallying, you should have sold a long time ago. Now back to Deltex , a rethink ???????????????????? | willib2 | |
01/3/2017 10:13 | Oops, " Eurodis " predictive texting lol. | gbenson1 | |
26/2/2017 13:00 | Not wishing to be negative but merely pointing out thoughts from the past that dont agree with the following recent comment. "I wonder if some of the recent flickers of life we see in the NHS may be down to the head to head trial with LID as well as other recent positive trial data. Hopefully starting to turn a few doctors' heads". A. It was stated that ALL the clinicians (Doctors) wanted ODM, 10 years ago. B. The clinicians (Doctors) DON'T pull the purse strings. Can't personally see that things have changed. | willib2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions